| Symbol | AGPU |
|---|---|
| Name | PREDICTIVE ONCOLOGY INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 91 43RD STREET,SUITE 110, PITTSBURGH, Pennsylvania, 15201, United States |
| Telephone | +1 412 432-1500 |
| Fax | — |
| — | |
| Website | https://www.predictive-oncology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001446159 |
| Description | Predictive Oncology Inc. is a science-driven company focused on applying its proprietary artificial intelligence to accelerate oncologic drug discovery and enable drug development. Predictive Oncology uses AI and its proprietary biobank of more than 150,000 tumor samples, categorized by tumor type, to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. The Company also creates and develops tumor-specific 3D cell culture models mimicking the physiological environment of human tissue, enabling better-informed decision-making during drug development. Predictive Oncologys suite of solutions supports oncology drug development from early discovery to clinical trials. Additional info from NASDAQ: |
(99% Positive) PREDICTIVE ONCOLOGY INC. (AGPU) Announces Business Combination
Read moreAxe Compute Secures Over $1.3 Billion in Global AI Infrastructure Customer Contracts
Read moreNew Form S-3/A - Axe Compute Inc. <b>Filed:</b> 2026-07-20 <b>AccNo:</b> 0001171843-26-004778 <b>Size:</b> 593 KB
Read moreAxe Compute Inc. Joins Russell Microcap® Index, Reflecting Its Growth as a Publicly Traded AI Infrastructure Platform
Read moreNew Form S-3/A - Axe Compute Inc. <b>Filed:</b> 2026-07-02 <b>AccNo:</b> 0001171843-26-004454 <b>Size:</b> 309 KB
Read moreAxe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute
Read moreNew Form S-3 - Axe Compute Inc. <b>Filed:</b> 2026-06-09 <b>AccNo:</b> 0001171843-26-004013 <b>Size:</b> 504 KB
Read moreBlacher Joshua 🟢 acquired 9.4K shares of Axe Compute Inc. (POAI) Transaction Date: May 14, 2026 | Filing ID: 003534
Read moreAxe Compute Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Rese… | — | Cancer, All Types | Unknown | 2019-03-21 | 2024-03-12 | ClinicalTrials.gov |